| Author | Campos, Luana Ferreira | |
| Author | Gabrielli, Ligia | |
| Author | Almeida, Maria da Conceição Chagas | |
| Author | Aquino, Estela Maria Leão | |
| Author | Matos, Sheila Maria Alvim | |
| Author | Griep, Rosane Harter | |
| Author | Aras, Roque | |
| Access date | 2022-06-13T14:10:08Z | |
| Available date | 2022-06-13T14:10:08Z | |
| Document date | 2021 | |
| Citation | CAMPOS, Luana Ferreira et al. Hormone therapy and Hypertension in Postmenopausal Women: Results from the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Arq Bras Cardiol., v. 118, n. 5, p. 905-913, 2022. | pt_BR |
| ISSN | 0066-782X | pt_BR |
| URI | https://www.arca.fiocruz.br/handle/icict/53230 | |
| Language | eng | pt_BR |
| Publisher | Sociedade Brasileira de Cardiologia | pt_BR |
| Rights | open access | pt_BR |
| Subject in Portuguese | Pós-menopausa | pt_BR |
| Subject in Portuguese | Terapia de reposição hormonal | pt_BR |
| Title | Hormone therapy and Hypertension in Postmenopausal Women: Results from the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) | pt_BR |
| Type | Article | pt_BR |
| DOI | 10.36660/abc.20210218 | |
| Abstract | Background: Hypertension is a major risk factor for cardiovascular morbidity and mortality in post-menopausal women.
Although menopausal hormone therapy (MHT) is a very effective treatment for vasomotor symptoms during this period,
the influence of this therapy on blood pressure is not yet clear.
Objective: To evaluate the relationship between the use of MHT and hypertension in participants of the ELSA-Brasil.
Methods: A cross-sectional study using the baseline ELSA-Brasil data in a cohort of 2,138 women who had
experienced natural menopause. This study analyzed hypertension, defined as arterial pressure ≥140/90 mmHg
or previous antihypertensive use, and use of MHT, with participants being classified into never, past, and
current users. Associations were assessed using an adjusted logistic regression model, with statistical significance
set at p<0.05.
Results: Overall, 1,492 women (69.8%) had never used MHT, 457 (21.4%) had used it in the past, and 189 (8.8%)
were current users. The use of MHT was more common in women who had a body mass index (BMI) <25 kg/m2 and
triglyceride levels <150 mg/dl, and who were physically less inactive, non-smokers, and non-diabetics. Current MHT
users were less likely to have hypertension (OR=0.59; 95% CI: 0.41-0.85) compared to those who had never used MHT.
In most cases, MHT was started at or before 59 years of age, within 10 years of becoming menopausal, and its use lasted
for up to five years. | pt_BR |
| Affilliation | Universidade Federal da Bahia. Programa de Pós-graduação em Medicina e Saúde. Salvador, BA, Brasil. | pt_BR |
| Affilliation | Universidade Federal da Bahia. Instituto de Saúde Coletiva. Salvador, BA, Brasil. | pt_BR |
| Affilliation | Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil. | pt_BR |
| Affilliation | Universidade Federal da Bahia. Instituto de Saúde Coletiva. Salvador, BA, Brasil. | pt_BR |
| Affilliation | Universidade Federal da Bahia. Instituto de Saúde Coletiva. Salvador, BA, Brasil. | pt_BR |
| Affilliation | Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Educação em Ambiente e Saúde. Rio de Janeiro, RJ, Brasil. | pt_BR |
| Affilliation | Universidade Federal da Bahia. Faculdade de Medicina da Bahia. Salvador, BA, Brasil. | pt_BR |
| Subject | Postmenopause | pt_BR |
| Subject | Hormone Replacement Therapy | pt_BR |
